Format

Send to

Choose Destination
Rev Esp Anestesiol Reanim. 2015 Jun;62 Suppl 1:57-62. doi: 10.1016/S0034-9356(15)30009-8.

[Treatment of anemia in hip fracture surgery].

[Article in Spanish]

Author information

1
Servicio de Anestesiología y Reanimación, Hospital Galdakao-Usansolo, Galdakao, Vizcaya, España. Electronic address: eduardo.garciapascual@osakidetza.net.

Abstract

Repairing hip fractures is one of the most common surgical procedures and has greater morbidity and mortality. This procedure is also a process that involves a greater need for blood products. Numerous factors influence morbidity, mortality and the use of blood products: patient age, concomitant diseases and drug treatments that change hemostasis and hemorrhaging (preoperative, intraoperative and postoperative), which are usually significant. On top of all this is the presence in a high percentage of cases of preoperative anemia, which can have one or more causes. It is therefore essential to establish an appropriate management of perioperative anemia and optimize the transfusion policy. The aim of this review is to briefly analyze the epidemiology of hip fractures as well as establish a basis for treating perioperative anemia and transfusion policies, proposing guidelines and recommendations for clinical management based on the most current studies.

KEYWORDS:

Anemia and hip fractures; Anemia y fractura de cadera; Preoperative assessment and hip fractures; Transfusion and hip fractures; Transfusión y fractura de cadera; Valoración preoperatoria y fractura de cadera

PMID:
26320346
DOI:
10.1016/S0034-9356(15)30009-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center